Marie A. Emson

3.3k total citations · 1 hit paper
24 papers, 1.6k citations indexed

About

Marie A. Emson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Marie A. Emson has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Otorhinolaryngology. Recurrent topics in Marie A. Emson's work include Head and Neck Cancer Studies (7 papers), Cerebrovascular and Carotid Artery Diseases (5 papers) and Breast Cancer Treatment Studies (4 papers). Marie A. Emson is often cited by papers focused on Head and Neck Cancer Studies (7 papers), Cerebrovascular and Carotid Artery Diseases (5 papers) and Breast Cancer Treatment Studies (4 papers). Marie A. Emson collaborates with scholars based in United Kingdom, Italy and Spain. Marie A. Emson's co-authors include Emma Hall, James P. Morden, Christopher M. Nutting, Kevin J. Harrington, Shreerang Bhide, Kate Newbold, Elizabeth Miles, Mark Sydenham, Teresa Guerrero Urbano and Catharine H. Clark and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Endocrinology.

In The Last Decade

Marie A. Emson

24 papers receiving 1.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

2011 1.2k citations Christopher M. Nutting, James P. Morden et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marie A. Emson United Kingdom	12	1.0k	810	583	414	312	24	1.6k
Rufus Scrimger Canada	20	696 0.7×	810 1.0×	348 0.6×	509 1.2×	289 0.9×	42	1.7k
W. Dobrowsky Austria	17	985 1.0×	690 0.9×	793 1.4×	196 0.5×	512 1.6×	55	1.6k
Jaiprakash Agarwal India	17	587 0.6×	455 0.6×	448 0.8×	145 0.4×	338 1.1×	42	1.0k
P Huguenin Switzerland	18	669 0.6×	568 0.7×	438 0.8×	137 0.3×	380 1.2×	37	1.3k
J.F. Greskovich United States	20	514 0.5×	756 0.9×	480 0.8×	120 0.3×	390 1.3×	70	1.2k
Francesco Miccichè Italy	22	497 0.5×	392 0.5×	667 1.1×	93 0.2×	749 2.4×	56	1.4k
Enis Özyar Türkiye	23	579 0.6×	546 0.7×	575 1.0×	245 0.6×	575 1.8×	117	1.7k
Maria Lai Hong Kong	11	725 0.7×	372 0.5×	399 0.7×	172 0.4×	405 1.3×	17	1.1k
Marije R. Vergeer Netherlands	18	514 0.5×	308 0.4×	287 0.5×	125 0.3×	266 0.9×	44	930
Indranil Mallick India	18	273 0.3×	412 0.5×	238 0.4×	239 0.6×	168 0.5×	88	920

Countries citing papers authored by Marie A. Emson

Since Specialization

Citations

This map shows the geographic impact of Marie A. Emson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie A. Emson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie A. Emson more than expected).

Fields of papers citing papers by Marie A. Emson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie A. Emson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie A. Emson. The network helps show where Marie A. Emson may publish in the future.

Co-authorship network of co-authors of Marie A. Emson

This figure shows the co-authorship network connecting the top 25 collaborators of Marie A. Emson. A scholar is included among the top collaborators of Marie A. Emson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie A. Emson. Marie A. Emson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nutting, Christopher M., Keith Rooney, Bernadette Foran, et al.. (2020). Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer.. Journal of Clinical Oncology. 38(15_suppl). 6508–6508. 23 indexed citations

Bhattacharya, Indrani, Laura Moretti, Joanne Haviland, et al.. (2018). Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies. Research Involvement and Engagement. 4(1). 22–22. 5 indexed citations

Brunt, Adrian Murray, Joanne Haviland, Mark Sydenham, et al.. (2018). FAST Phase III RCT of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015). International Journal of Radiation Oncology*Biology*Physics. 102(5). 1603–1604. 34 indexed citations

Nutting, Chris, James P. Morden, Matthew Beasley, et al.. (2017). PO-093: COSTAR trial results: 3-D Conformal Radiotherapy vs Cochlea-Sparing IMRT in parotid cancer patients. Radiotherapy and Oncology. 122. 44–45. 1 indexed citations

Petkar, Imran, Keith Rooney, Justin Roe, et al.. (2016). DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. BMC Cancer. 16(1). 770–770. 72 indexed citations

Macdonald, Lindsay, Zoë Winters, Sarah Edwards, et al.. (2016). How informed is declared altruism in clinical trials? A qualitative interview study of patient decision-making about the QUEST trials (Quality of Life after Mastectomy and Breast Reconstruction). Trials. 17(1). 431–431. 18 indexed citations

Nutting, Christopher M., James P. Morden, Matthew Beasley, et al.. (2016). First results of COSTAR: A randomised trial of 3-dimensional conformal radiotherapy (3DCRT) vs cochlea-sparing intensity modulated radiotherapy (CS-IMRT) in patients with parotid cancer.. Journal of Clinical Oncology. 34(15_suppl). 6006–6006. 3 indexed citations

Gujral, Dorothy M., James P. Morden, Marie A. Emson, et al.. (2013). Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial. Oral Oncology. 50(2). 141–146. 4 indexed citations

Palmieri, Carlo, Constantine Alifrangis, David Shipway, et al.. (2012). A Randomized Feasibility Study of Docetaxel Versus Vinorelbine in Advanced Breast Cancer. The Oncologist. 17(11). 1429–1429. 4 indexed citations

10.

Nutting, Christopher M., James P. Morden, Kevin J. Harrington, et al.. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. The Lancet Oncology. 12(2). 127–136. 1202 indexed citations breakdown →

11.

Winters, Zoë, J. Mills, Lucy Kilburn, et al.. (2009). The QUEST Trial: A multi-centre randomised trial to assess the impact of the type and timing of breast reconstruction on quality of life following mastectomy. European Journal of Surgical Oncology. 35(11). 1217–1217. 3 indexed citations

12.

Nitti, Donato, J. Wils, George Fountzilas, et al.. (2005). Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Annals of Oncology. 17(2). 262–269. 67 indexed citations

13.

Coombes, R. Charles, Anthony Howell, Marie A. Emson, et al.. (2005). High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial. Annals of Oncology. 16(5). 726–734. 35 indexed citations

14.

Coombes, R. Charles, L.J. Gibson, Emma Hall, Marie A. Emson, & Judith M. Bliss. (2003). Aromatase inhibitors as adjuvant therapies in patients with breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 86(3-5). 309–311. 14 indexed citations

15.

Byrd, Sheila, Peter Robless, Alexander Baxter, Marie A. Emson, & Alison Halliday. (2000). Carotid duplex ultrasonography: Importance of standardisation. International Dental Journal. 50. 248–254. 4 indexed citations

16.

Robless, Peter, Marie A. Emson, Daniel Thomas, A O Mansfield, & Alison Halliday. (1998). Are we detecting and operating on high risk patients in the asymptomatic carotid surgery trial?. European Journal of Vascular and Endovascular Surgery. 16(1). 59–64. 8 indexed citations

17.

Robless, Peter, et al.. (1998). The prevalence of cerebral infarcts in the Asymptomatic Carotid Surgery Trial (ACST) in relation to prior contralateral symptoms.. PubMed. 17(3). 187–93. 8 indexed citations

18.

Robless, Peter, et al.. (1998). Prevalence of asymptomatic CT infarcts in the ongoing Asymptomatic Carotid Surgery Trial (ACST).. PubMed. 17(3). 194–200. 8 indexed citations

19.

Doré, Caroline J, Marie A. Emson, D.R. Springall, et al.. (1997). Stereological estimation of blood vessel surface and volume densities in human normal and rhinitic nasal mucosa.. PubMed. 35(1). 22–7. 14 indexed citations

20.

Steel, Jennifer H., Domhnall O’Halloran, Marie A. Emson, et al.. (1992). Identification of bombesin-immunoreactive cells in rat, human, and other mammalian pituitaries, their ontogeny and the effect of endocrine manipulations in the rat.. Endocrinology. 130(5). 2587–2596. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact